Thank you. I appreciate that.
The second issue is with respect to the capital cost allowance. It's obviously something I know very well, because I was the chair of the committee, and I know Canada's chemical producers and other groups were very instrumental in bringing that issue forward.
I think one of the issues relates to what was said about the research issue. The more practical examples you have of research actually coming forward and having an impact are the same with respect to this issue. My understanding from your industry and from groups like the Canadian Manufacturers and Exporters is that the accelerated capital cost allowance has caused companies to actually make investments. I've toured a number of companies over the past number of months where plant managers walked me through and said, “Those two machines that are a million dollars plus were bought in part because of the accelerated capital cost allowance”.
You may want to comment on this, the two of you, but this is what you have to show, then, to this committee and to the government, and say that because the government has done this with accelerated capital cost, these are the investments that have been made, and if you keep it going for a five-year period, this is the type of further investment that will be made to address the productivity concern that Mr. McKay had.
Can I get one or both of you to address that?